Dr. Martens plc: marching towards turnaround

(Full access for Members only)

Image: Cineberg / Shutterstock.com

Dr. Martens plc: marching towards turnaround

10 May 2023

Successful, timeless brands don't come up for a discounted sale very often. Will Dr. Martens' recent issues turn out temporary, and allow contrarian investors to pick up stock at bargain prices?

I believe this is more likely than not, and the starting gun will be fired on 1 June 2023.

My latest report looks at:

  • How well the brand is doing in most markets.
  • Just how much headroom to grow the company still has.
  • How undervalued the stock is both in absolute and relative terms.

If you ever considered looking at Dr. Martens as an investment rather than a way to channel your inner rebel, now is a good time to do so – and I have already done the hard work for you!

Not a Member yet? Sign up for a Membership - just USD 49/year.
Already a Member? Log into your account to download the report.

Most recent

Latest reports (for Members only)

Laggard turning growth stock

Laggard turning growth stock

This European market leader has a 3x-5x upside over the coming 3-5 years if new management gets its growth engines revved up again. Will it?

Undervalued liquidation case

Undervalued liquidation case

This London-listed stock could throw off 3-3.5x the current share price. Funds specialised in complex special situations have already taken note.

Mid-cap bid target

Mid-cap bid target

The company's CEO and COO have been given a strong financial incentive to at least double the share price by mid-2026. They are likely to succeed.